ASP2215 (gilteritinib)

gilteritinib · Astellas Pharma

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ASP2215 (gilteritinib), covering 2024-11-05 to 2024-11-05. Get the full timeline:

Most recent: Clinical Trial Update: A Study of ASP2215 in Combination With Induction and Consolidation Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia [Phase 1]

See pricing